Safety, Pharmacokinetics, and Pharmacodynamics of a Dipeptidyl Peptidase-4 Inhibitor: A Randomized, Double-Blinded, Placebo-Controlled Daily Administration of Fotagliptin Benzoate for 14 Days for Type 2 Diabetes Mellitus

Wu, M; Li, QQ; Zhang, H; Zhu, XX; Li, XJ; Li, Y; Sun, HG; Ding, YH

Ding, YH (corresponding author), First Hosp Jilin Univ, Dept Phase 1, Clin Trial Unit, Changchun 130021, Jilin, Peoples R China.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, ; ():